相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2 A Randomized Clinical Trial
George W. Sledge et al.
JAMA ONCOLOGY (2020)
Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer
Yoon-Sim Yap et al.
CANCER SCIENCE (2020)
Development and Application of a Mechanistic Population Modeling Approach to Describe Abemaciclib Pharmacokinetics
Emmanuel Chigutsa et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2020)
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer
Stephen Johnston et al.
NPJ BREAST CANCER (2019)
Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study
Norikazu Masuda et al.
CANCER SCIENCE (2018)
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
Debu Tripathy et al.
LANCET ONCOLOGY (2018)
Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2-advanced breast cancer
Silvia Paola Corona et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
The association of early toxicity and outcomes for patients treated with abemaciclib
Hope S. Rugo et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
CDK4/6 inhibition in breast cancer: current practice and future directions
Sonia Pernas et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Epidemiology, Incidence and Mortality of Breast Cancer in Asia
Mahshid Ghoncheh et al.
Asian Pacific Journal of Cancer Prevention (2017)
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2-Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
George W. Sledge et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
Matthew P. Goetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
HR+, HER2-Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles
Sarah L. Sammons et al.
CURRENT CANCER DRUG TARGETS (2017)
MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2- Metastatic Breast Cancer
Maura N. Dickler et al.
CLINICAL CANCER RESEARCH (2017)
PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Progressed on Prior Endocrine Therapy-Safety and Efficacy in Asian Patients
Hiroji Iwata et al.
JOURNAL OF GLOBAL ONCOLOGY (2017)
Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
Hope S. Rugo et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors
Amita Patnaik et al.
CANCER DISCOVERY (2016)
Phase Ib/II study of LEE011 and BYL719 and letrozole in ER+, HER2-breast cancer: Safety, preliminary efficacy and molecular analysis
Dejan Juric et al.
CANCER RESEARCH (2015)
Female Breast Cancer Incidence Among Asian and Western Populations: More Similar Than Expected
Hyuna Sung et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Female Breast Cancer Incidence Among Asian and Western Populations: More Similar Than Expected
Hyuna Sung et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Overcoming endocrine resistance in metastatic breast cancer: Current evidence and future directions
Andrea Milani et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
Effects of lifestyle and single nucleotide polymorphisms on breast cancer risk: a case-control study in Japanese women
Taeko Mizoo et al.
BMC CANCER (2013)
Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer
Keith T. Flaherty et al.
CLINICAL CANCER RESEARCH (2012)
Epidemiology, screening and diagnosis of breast cancer in the Asia-Pacific region: Current perspectives and important considerations
Michael Green et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2008)
To cycle or not to cycle: A critical decision in cancer
M Malumbres et al.
NATURE REVIEWS CANCER (2001)
分享论文
